<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139669">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02063282</url>
  </required_header>
  <id_info>
    <org_study_id>ShaareZMC</org_study_id>
    <nct_id>NCT02063282</nct_id>
  </id_info>
  <brief_title>The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers</brief_title>
  <official_title>The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amos Yinnon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shaare Zedek Medical Center</source>
  <oversight_info>
    <authority>Israel: Israeli Health Ministry Pharmaceutical Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that development of symptoms characteristic of Clostridium
      difficile infection will be 2-3 times higher in asymptomatic carriers, compared to that  of
      non carriers and expect to find risk factors for development of symptomatic clostridium
      difficile.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>2 Weeks</target_duration>
  <primary_outcome>
    <measure>Development of colitis</measure>
    <time_frame>Daily follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Patients' file will be reviewed and the next signs and symptoms will be recorded: abdominal pain, diarrhea, fever and leukocytosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration until development of colitis</measure>
    <time_frame>Daily follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Patients' file will be reviewed and the next signs and symptoms will be recorded: abdominal pain, diarrhea, fever and leukocytosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of colitis</measure>
    <time_frame>Daily follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>participants will be followed for the duration of hospital stay, an expected average of 4 weeks.
Patients' file will be reviewed and the next signs and symptoms will be recorded: abdominal pain, diarrhea, fever and leukocytosis.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">744</enrollment>
  <condition>Clostridium Difficile</condition>
  <condition>Colitis</condition>
  <arm_group>
    <arm_group_label>Clostridium difficile carriers</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Clostridium difficile non carriers</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Newly admitted patients in the Emergency Department and Internal wards, .
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of hospitalization in recent year, residence of a nursing home or
             institutions

          -  Expected more than 48 hours hospitalization

        Exclusion Criteria:

          -  Colitis/ diarrhea

          -  Rectal swab performed â‰¥48 hrs post arrival to hospital.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amos Yinnon, Professor</last_name>
    <phone>02-6555147</phone>
    <email>yinnon@szmc.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Yonit Wiener-Well, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eliyahu Ben Shitrit, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shelly Kagan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amos M Yinnon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://archinte.jamanetwork.com/article.aspx?articleid=622162</url>
  </link>
  <link>
    <url>http://archinte.jamanetwork.com/article.aspx?articleid=1697791</url>
  </link>
  <link>
    <url>http://www.ajicjournal.org/article/S0196-6553(12)01303-X/abstract</url>
  </link>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 13, 2014</lastchanged_date>
  <firstreceived_date>February 11, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shaare Zedek Medical Center</investigator_affiliation>
    <investigator_full_name>Amos Yinnon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Asymptomatic</keyword>
  <keyword>Carriage</keyword>
  <keyword>Colonization</keyword>
  <keyword>Clostridium difficile</keyword>
  <keyword>Colitis</keyword>
  <keyword>Rectal swab</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
